Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Deferred Taxes (2016)

Historic Deferred Taxes for Pharma (IGC) over the last 8 years, with Q1 2016 value amounting to $579.0.

  • Pharma's Deferred Taxes fell 8148.98% to $579.0 in Q1 2016 from the same period last year, while for Mar 2016 it was $3707.0, marking a year-over-year increase of 1851.02%. This contributed to the annual value of $18968.0 for FY2017, which is 317599.31% up from last year.
  • As of Q1 2016, Pharma's Deferred Taxes stood at $579.0, which was down 8148.98% from $3128.0 recorded in Q1 2015.
  • In the past 5 years, Pharma's Deferred Taxes registered a high of $863953.0 during Q1 2012, and its lowest value of -$522498.0 during Q1 2013.
  • Over the past 5 years, Pharma's median Deferred Taxes value was $1596.0 (recorded in 2013), while the average stood at $33176.5.
  • Over the last 5 years, Pharma's Deferred Taxes had its largest YoY gain of 27851.41% in 2013, and its largest YoY loss of 16047.76% in 2013.
  • Over the past 5 years, Pharma's Deferred Taxes (Quarter) stood at $498.0 in 2012, then soared by 278.51% to $1885.0 in 2013, then surged by 684.67% to $14791.0 in 2014, then tumbled by 78.85% to $3128.0 in 2015, then crashed by 81.49% to $579.0 in 2016.
  • Its Deferred Taxes was $579.0 in Q1 2016, compared to $3128.0 in Q1 2015 and $14791.0 in Q1 2014.